Immunicum AB (1YG0) Stock Statistics & Valuation Metrics

Immunicum AB has a market cap or net worth of €32.85M. The enterprise value is €315.78M.

Immunicum AB has 52,084,580 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunicum AB’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -19.56%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Immunicum AB had revenue of 5.05M and earned -128.40M in profits. Earnings per share was -2.64.

In the last 12 months, operating cash flow was -64.29M and capital expenditures -526.00K, giving a free cash flow of -64.82M billion.

Immunicum AB pays an annual dividend of ―, resulting in a dividend yield of ―

Immunicum AB upcoming earnings date is ―, ―.

Immunicum AB as a current ratio of 4.29, with Debt / Equity ratio of 3.30%

In the past 12 months, Immunicum AB has paid 0.00 in taxes.

Immunicum AB EV to EBITDA ratio is -2.42, with an EV/FCF ratio of -3.68.

Immunicum AB has €84.73M in cash and marketable securities with kr20.29M in debt, giving a net cash position of -€64.44M billion.

Gross margin is 100.00%, with operating margin of -2588.25%, and net profit margin of -2543.56%.

The average price target for Immunicum AB is €0.67, which is 11.43% higher than the current price. The consensus rating is Hold